Tainan, Taiwan

Hung Wei Chuang

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Scniopharm Taiwan, Ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hung Wei Chuang. Retrieved from https://idiyas.com/inventor/hung-wei-chuang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hung Wei Chuang in Bivalirudin Synthesis

Introduction

Hung Wei Chuang is a notable inventor based in Tainan County, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. His work has implications for medical treatments and drug development.

Latest Patents

Hung Wei Chuang holds a patent for a process related to the efficient commercial synthesis of Bivalirudin. This invention is crucial as Bivalirudin is an anticoagulant used in various medical procedures. His innovative approach enhances the production efficiency of this important drug.

Career Highlights

Hung Wei Chuang is associated with Scniopharm Taiwan, Ltd., where he applies his expertise in pharmaceutical synthesis. His career reflects a commitment to advancing medical science through innovative solutions. He has been instrumental in developing processes that improve drug manufacturing.

Collaborations

Hung Wei Chuang has worked alongside talented colleagues, including Tsung Yu Hsiao and Jin Guo Ding. Their collaborative efforts contribute to the success of their projects and the advancement of pharmaceutical technologies.

Conclusion

Hung Wei Chuang's contributions to the synthesis of Bivalirudin exemplify the impact of innovation in the pharmaceutical industry. His work not only enhances drug production but also supports advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…